Educated Patient® Webinar: Biomarkers, Why Genomic Testing Matters

June 30th 2021

View the full CURE® Educated Patient® Webinar: Biomarkers, Why Genomic Testing Matters on demand.

Patient Enrollment in Clinical Trials Can Benefit Outcomes and Expand Research

June 30th 2021

According to an expert from The University of Texas MD Anderson Cancer Center, patient enrollment in clinical trials that involve genomic testing are important in progressing research in their cancer types.

Educating Patients on Germline and Somatic Testing

June 30th 2021

Drs Benjamin Levy and Lori J Wirth describe the differences between germline and somatic mutations, explain how these are detected and used to guide treatment for lung and thyroid cancer, and comment on counseling patients about concerns of hereditary findings.

Molecular Testing and Novel Therapies for NSCLC

June 30th 2021

Benjamin Levy, MD, briefly describes the difference between driver mutations and immunotherapy biomarkers in non–small cell lung cancer and explains how decisions for immunotherapy or targeted therapy are made based on results of molecular assays.

Classification of Renal Cell Carcinoma

June 29th 2021

An expert in urologic oncology reviews the staging, grade, and types of renal cell carcinoma.

Overview of Renal Cell Carcinoma (RCC)

June 29th 2021

Thomas E. Hutson, DO, PharmD, provides insight on the diagnosis of renal cell carcinoma (RCC) and discusses classic signs and symptoms of the disease.

When Treatment Options Run Out, Consider a Higher Drug Dose in GIST

June 29th 2021

In patients with advanced gastrointestinal stromal tumors, a dose escalation of Qinlock after recommended treatment with the agent may be the best next step, answering for the lack of a next approved agent after Qinlock.

First-Line Treatment Options for laBCC

June 29th 2021

Anna C. Pavlick, DO, provides an overview of hedgehog inhibitors, a first-line treatment option for patients diagnosed with locally advanced basal cell carcinoma (laBCC).

Multidisciplinary Management of laBCC

June 29th 2021

A discussion about multidisciplinary management of locally advanced basal cell carcinoma (laBCC) and how dermatologists and medical oncologists collaborate within the care of a patient.

laBCC: Skin Biopsy

June 29th 2021

An expert discusses features of a skin lesion that would prompt a skin biopsy in the diagnosis of locally advanced basal cell carcinoma (laBCC).

laBCC Overview

June 29th 2021

Anna C. Pavlick, D.O., provides an overview of locally advanced basal cell carcinoma (laBCC) that includes the different risk factors and clinical presentations.

New Potential Immunotherapy Treatment Options in Advanced Esophageal Squamous Cell Carcinoma

June 28th 2021

Opdivo was the first PD-1 inhibitor to show durable responses in patients with esophageal squamous cell carcinoma.

Educated Patient® Skin Cancer Summit: June 26, 2021

June 26th 2021

View the full CURE Educated Patient Skin Cancer Summit on demand.

Combination Therapy May Provide New Treatment Option for Patients with Lymphoma

June 23rd 2021

Monjuvi and Revlimid attained extended remission and improved survival in patients with relapsed or refractory diffuse large B-cell lymphoma.

Molecular Testing in Thyroid Cancer: Interpreting Results

June 23rd 2021

Lori J. Wirth, MD, describes what information she looks for from results of molecular testing that help inform treatment for her patients with thyroid cancer.

Molecular Testing and Shared Decision-Making

June 23rd 2021

Andrea Ferris, of the LUNGevity Foundation, explains why shared decision-making is important when recommending molecular testing to patients with lung or thyroid cancer and highlights resources provided through her organization that support patients and health care professionals.

Dose Escalation of Qinlock Shows Benefit in Patients With Advanced GIST

June 22nd 2021

The findings open up the door for a fourth-line treatment option in patients with advanced gastrointestinal stromal tumors with disease progression.

Increasing Research to Address Challenges in Gastric Cancer

June 18th 2021

Dr. Yanghee Woo highlights barriers that patients with gastric cancer face when looking to enroll in a clinical trial, and comments on the need for more participation in research trials that investigate ways to improve how the condition is screened for and treated.

Educating Patients About Biomarker Testing

June 16th 2021

Common questions asked by patients with lung or thyroid cancer who have been referred for biomarker testing and advice for setting expectations from test results.

The Emerging Role of Liquid Biopsies

June 16th 2021

Drs Benjamin Levy and Lori J. Wirth comment on the current role of liquid biopsies in lung and thyroid cancer.

Better Prostate Cancer Screening for Younger African American Men May Improve Outcomes

June 16th 2021

Reaching a younger age group of African American men for prostate cancer detection may improve their survival outcomes, says an expert from the University of California San Diego.

Initial Diagnosis of Triple-Negative Breast Cancer

June 15th 2021

Latasha Jordan, a triple-negative breast cancer survivor, discusses challenges she faced with her symptoms and diagnosis, and Aditya Bardia, M.D., MPH, reviews the typical diagnostic work-up used to determine a treatment approach.

Importance of Clinical Trials for Gastric Cancer

June 11th 2021

Dr. Sam Klempner describes limitations in caring for patients with gastric cancer and emphasizes the importance of participation in clinical trials to help advance treatment.

Raising Awareness About Gastric Cancer in Young Adults

June 11th 2021

Sam Klempner, M.D., of Massachusetts General Hospital, highlights common symptoms that may prompt an evaluation for gastric cancer in young adults and explains why patients and health care professionals need further education on the management of the disease.

Bladder-Saving Treatment Regimen Shows Promise in Patients with Bladder Cancer

June 10th 2021

A combination of treatment with bladder-saving surgical resection, Opdivo and chemotherapy yielded positive results in patients with muscle-invasive bladder cancer.

Palliative Care Improves Coping in Patients with A Certain Type of Leukemia

June 9th 2021

Introducing integrated palliative care to patients with a certain type of leukemia was shown to facilitate active coping strategies, which could improve a patient’s quality of life.

Best Practices When Testing With Comprehensive Genomic Profiling

June 9th 2021

Recommendations for selecting appropriate patients for comprehensive genomic profiling and navigating through the testing process.

Comprehensive Genomic Profiling in Lung and Thyroid Cancer

June 9th 2021

Drs Benjamin Levy and Lori J. Wirth describe how they currently utilize comprehensive genomic profiling to manage patients with non–small cell lung cancer or thyroid cancer.

Novel Therapy Shows Promise in Group of Patients with Metastatic Colon Cancer

June 7th 2021

Responses to the study drug, according to one of the study’s authors, appeared far superior than what would have been expected with other treatments in patients with HER2-expressing metastatic colorectal cancer.

‘Incredible’ That a One-Time Infusion of CAR-T Cell Therapy Induces Durable Responses in Acute Lymphoblastic Leukemia

June 6th 2021

Although recent data show how promising a single-infusion of a specific CAR-T cell therapy may be for patients with acute lymphoblastic leukemia, an expert from the Moffitt Cancer Center notes that more research is needed for those deemed too ill to receive the treatment.